Company 1 identity field
Location
Silver Spring, MD
SEC filing record 1 source field
Fiscal year end
31 December
UNITED THERAPEUTICS Corp has filed 4,226 SEC EDGAR filings since 16 Apr 1999

SEC filing history

Showing 451-475 of 1,000 matching filings.

Per page
25
Current page
19
144 File 000-26301

144 filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-57843

SCHEDULE 13G/A filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-57843

SCHEDULE 13G filing

Filing date
05 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jan 2025
Reporting date
21 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Jan 2025
Reporting date
16 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jan 2025
Reporting date
13 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jan 2025
Reporting date
10 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
13 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
10 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jan 2025
Reporting date
06 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Dec 2024
Reporting date
30 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Dec 2024
Reporting date
30 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
30 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Dec 2024
Reporting date
23 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Dec 2024
Reporting date
19 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Dec 2024
Reporting date
18 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
18 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2024
Reporting date
16 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
16 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Dec 2024
Reporting date
09 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Dec 2024
Reporting date
05 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .